FAM
SUPN icon

Fred Alger Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Fred Alger Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,500
Closed -$711K – 537
2017
Q2 		$711K Buy
16,500
+500
+3% +$17.8K ﹤0.01% 351
2017
Q1 		$501K Buy
16,000
+6,000
+60% +$161K ﹤0.01% 360
2016
Q4 		$253K Sell
10,000
-20,000
-67% -$447K ﹤0.01% 345
2016
Q3 		$742K Buy
30,000
+8,000
+36% +$181K ﹤0.01% 326
2016
Q2 		$448K Buy
22,000
+13,000
+144% +$231K ﹤0.01% 385
2016
Q1 		$137K Buy
+9,000
New +$117K ﹤0.01% 450

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Fred Alger Management's SUPN Position: Q3 2017 in Review

Fred Alger Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2017, closing a stake of 16,500 shares — an estimated $711K sold.

Fred Alger Management first reported a position in SUPN in Q1 2016 and held it in 6 quarters. The position peaked at $742K in Q3 2016. 275 funds tracked by Wall St. Rank hold SUPN as of Q3 2017.

  • Fred Alger Management reported no remaining Supernus Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Fred Alger Management sold 16,500 Supernus Pharmaceuticals shares in Q3 2017, an estimated $711K.
  • Fred Alger Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Fred Alger Management's Supernus Pharmaceuticals position peaked at $742K in Q3 2016.
  • 275 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2017.

Based on Fred Alger Management's 13F filing for Q3 2017, filed 14 Nov 2017.